Study Stopped
Departure of the PhD in charge of the study
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
VASCIP
1 other identifier
interventional
4
1 country
1
Brief Summary
Paraplegic patients have defective wound healing for sore below the level of spinal lesion. Defect of vascularization of the healing zone certainly participate to this effect. Therefore, this study want to measure, in a clinical settings, the interface pressure (e.g. the pressure between the patient body and the surface he/she is lying on) to assess the correlation between mechanical stress in term of pressure applied over time and tissue oxygenation which represent micro-vascular function. The aim of this clinical trial is to correlate the variations of pressure intensities and changes in micro-vascularization. The measure are recorded when paraplegic patient came into the hospital for pressure ulcer related surgery. The patient is laying on his/her mattress on top of a flexible pressure mapping device. The micro-vascularization parameters are measured at the area displaying the peak pressure a few minutes after the beginning of the pressure interface recording and one hour later at the same area. The data generated during this monocentric study will help to achieve a better understanding of the relation between pressure and micro-vascularization. In the mid term, it will provide a better and more patient adapted pressure ulcer prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2017
CompletedFirst Posted
Study publicly available on registry
April 14, 2017
CompletedStudy Start
First participant enrolled
November 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 22, 2019
CompletedDecember 9, 2021
December 1, 2021
2 years
March 30, 2017
December 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Measure of the pressure intensity in one area
Pressure intensity is recorded using a mapping pressure device (XSensor), set up on the patient hospital bed. Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
Measure of the hemoglobin quantity in the same area
Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
Secondary Outcomes (1)
Measure of other micro-vascularization related parameters (such as the oxygen saturation and the blood flow) recorded at the same area.
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
Study Arms (1)
Single arm
OTHERMeasurement of interface pressure and Measurement of micro-vascularization related parameters
Interventions
A capacitive pressure mapping device (XSensor) is set up on the patient air mattress bed. It records the interface pressure on the whole patient body with one frame every second during one hour. Then the file is saved and the pressure mapping device is removed from the patient hospital bedroom.
A medical device called O2C, measuring micro-vascularization related parameters (oxygen saturation, hemoglobin quantity and blood flow) is used. The probe (= an optic fibre) is set up lightly on the patient skin or on a transparent adhesive for 1 minute. The median value of the local micro-vascularization parameters are saved on the O2C interface. The location of the measurement is chosen using the pressure mapping device to locate peak pressure area. Then the O2C is removed from the patient hospital bedroom.
Eligibility Criteria
You may qualify if:
- Educated consent signed,
- Older than 18,
- Paraplegia for at least 6 months,
- Surgery planned for pressure ulcer resection,
You may not qualify if:
- Dementia,
- Stade IV arteritis non-revascularisable,
- Patient with no health insurance,
- Pregnant women or breast-feeding, patient unable to give his or her educated consent, ward of the state (art. L.1121-6, L.1121-7, L.1211-8, L.1211-9),
- Patient taking part in another study which could impact the local micro-vascularization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- Hill-Romcollaborator
- Institut National de la Santé Et de la Recherche Médicale, Francecollaborator
Study Sites (1)
University Regional Hospital Lapeyronie
Montpellier, Languedoc-Roussillon, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Matecki, M.D.
CHU de Montpellier
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2017
First Posted
April 14, 2017
Study Start
November 22, 2017
Primary Completion
November 22, 2019
Study Completion
November 22, 2019
Last Updated
December 9, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share